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Wolbachia are maternally inherited intracellular
bacterial symbionts that are estimated to infect
more than 60% of all insect species. WhileWolbachia
is commonly found in many mosquitoes it is absent
from the species that are considered to be of major
importance for the transmission of human patho-
gens. The successful introduction of a life-shortening
strain of Wolbachia into the dengue vector Aedes
aegypti that halves adult lifespan has recently been
reported. Here we show that this same Wolbachia
infection also directly inhibits the ability of a range
of pathogens to infect this mosquito species. The
effect is Wolbachia strain specific and relates to
Wolbachia priming of the mosquito innate immune
system and potentially competition for limiting
cellular resources required for pathogen replication.
We suggest that this Wolbachia-mediated pathogen
interference may work synergistically with the life-
shortening strategy proposed previously to provide
a powerful approach for the control of insect trans-
mitted diseases.
INTRODUCTION
Vector-borne diseases such as malaria, leishmaniasis and
dengue, cause a tremendous impact on human mortality and
morbidity worldwide. With increasing human movement (Adams
and Kapan, 2009) and global warming effects (Barclay, 2008;
Pachauri and Reisinger, 2007) re-emerging arboviral pathogens
(Gould and Solomon, 2008) such as dengue (DENV) and Chikun-
gunya (CHIKV) viruses are becoming an increasing threat
(Ng and Ojcius, 2009; Staples et al., 2009).1268 Cell 139, 1268–1278, December 24, 2009 ª2009 Elsevier Inc.Dengue is currently the most significant arboviral disease
afflicting tropical and sub-tropical communities worldwide with
an estimated global annual incidence of 50 million cases leading
to tens of thousands of deaths (WHO, 2009). Between 2004 and
2007, unprecedented outbreaks of CHIKV occurred in islands of
the western Indian Ocean, the Indian subcontinent and Europe
(Staples et al., 2009). Aedes aegypti is considered the primary
vector of both DENV and CHIKV. As effective vaccines do not
exist for these viruses, prevention of human cases relies almost
exclusively on control of the mosquito vectors. Despite some
recent successes utilizing copepods as larval biological control
agents (Kay and Vu, 2005), most control approaches are proving
neither effective nor sustainable, and dengue is increasing in its
geographic distribution, frequency of outbreaks and severity of
disease (Kyle and Harris, 2008).
A new approach to dengue control has recently been
proposed that targets mosquito longevity rather than abun-
dance, through the introduction of a life-shortening strain of
the bacterium Wolbachia pipientis into A. aegypti populations
(Brownstein et al., 2003; Cook et al., 2008; Rasgon et al., 2003;
Sinkins and O’Neill, 2000). Wolbachia is an intracellular inherited
bacterium, predicted to naturally infect more than 60% of all
insect species worldwide (Hilgenboecker et al., 2008; Jeyapra-
kash and Hoy, 2000) that is able to invade host populations
through either the induction of a number of reproductive para-
sitism traits (O’Neill et al., 1997) or by positively influencing
host fitness (Brownlie et al., 2009; Dobson et al., 2004; Kremer
et al., 2009; Weeks et al., 2007).
Since the extrinsic incubation period of viruses and parasites
within the mosquito vector is long relative to insect lifespan, Wol-
bachia infections that can invade mosquito populations and
reduce adult A. aegypti lifespan are predicted to reduce path-
ogen transmission without eliminating the mosquito population
(Brownstein et al., 2003; Rasgon et al., 2003; Sinkins and O’Neill,
2000). The successful introduction of the life-shortening wMel-
Pop-CLA strain of Wolbachia from Drosophila melanogaster
Table 1. Effect ofWolbachia on DENV-2 Infection
PGYP1.out (+ Wolb) PGYP1.out.tet ( Wolb) Cairns3 ( Wolb)
Experiment
Log DENV-2
per mL
Days post-
infection
% body
infection (n)
% disseminated
infection (n)
% body
infection (n)
% disseminated
infection (n)
% body
infection (n)
% disseminated
infection (n)
1 6.3 7 0 (25) 0 (25) NAa NA 64 (25) 12 (25)
14 0 (27) 0 (27) NA NA 57 (30) 23 (30)
2 6.0 7 0 (40) 0 (40) 100 (30) 10 (30) 95 (40) 5 (40)
14 0 (40) 0 (40) 97 (30) 37 (30) 95 (40) 20 (40)
3 5.3 7 0 (40) 0 (40) 30 (40) 23 (40) 50 (40) 13 (40)
14 0 (40) 0 (40) 48 (40) 43 (40) 73 (40) 33 (40)
4 7.8 7 5 (40) 3 (40) 78 (40) 63 (40) 63 (40) 45 (40)
14 8 (40) 5 (40) 70 (40) 65 (40) 75 (40) 70 (40)
A. aegypti were orally infected with fresh DENV-2 and viral load determined by cell culture ELISA.
a This mosquito line was unavailable for experiment 1into A. aegypti has recently been reported (McMeniman et al.,
2009). Mosquitoes carrying this Wolbachia strain show around
a 50% reduction in adult female lifespan compared to uninfected
mosquitoes.
Recent studies in Drosophila have shown that Wolbachia
infections can protect against RNA viruses (Hedges et al.,
2008; Teixeira et al., 2008). The Wolbachia strains wMelCS and
wMelPop that infect D. melanogaster were found to delay
mortality in flies when they were infected with a range of patho-
genic viruses including Drosophila C virus, Flock House virus and
Cricket paralysis virus. It is currently unknown how general this
anti-viral effect is in terms of both the diversity of Wolbachia
strains that can confer protection and the range of viruses that
are affected by it although recent studies in Drosophila indicate
that the effect appears limited to certain Wolbachia strains (Os-
borne et al., 2009).
Given that the wMelPop strain of Wolbachia provides protec-
tion against RNA viruses in Drosophila, and that the derived
wMelPop-CLA strain of Wolbachia was introduced into the
mosquito A. aegypti to shorten lifespan, we hypothesized that
wMelPop-CLA infected mosquitoes may have altered vector
competence for arboviruses. To test this hypothesis we exposed
Wolbachia-infected and -uninfected mosquitoes to two impor-
tant human pathogens; dengue and Chikungunya viruses. We
also tested the same mosquito strains with the avian malaria
parasite, Plasmodium gallinaceum.
RESULTS
Wolbachia and Dengue Virus
We tested the effect of Wolbachia on vector competence in two
mosquito genetic backgrounds: the original inbred PGYP1 line,
stably transinfected with wMelPop-CLA (McMeniman et al.,
2009) and the same strain after five generations of backcrossing
to the F1 progeny of wild-caught A. aegypti, collected in Cairns,
Australia (PGYP1.out). These mosquito strains were compared
to tetracycline-treated counterparts that were genetically iden-
tical but lacked the Wolbachia infection, named PGYP1.tet and
PGYP1.out.tet, respectively. In addition, a wild-type strain of A.
aegypti established from field-collected material in Cairns,
Australia (Cairns3) was used as an additional negative control.CMosquitoes were fed an artificial blood meal spiked with
DENV-2 in four independent experiments to examine possible
interactions with Wolbachia. The presence of DENV-2 in whole
mosquito bodies was examined 7 and 14 days post exposure
using a cell culture enzyme immunoassay (CCEIA) (Knox et al.,
2003). In three separate experiments no Wolbachia-infected
mosquitoes (PGYP1.out) tested positive for DENV-2, but
DENV-2 infection rates in Wolbachia-uninfected mosquitoes
(PGYP1.out.tet and Cairns3) ranged from 30%–100% (Table 1,
Exp 1–3). Body viral infection rates in PGYP1.out.tet mosquitoes
ranged from 30%–100% after 7 days and 48%–97% after
14 days, while the body viral infection rates in Cairns3 ranged
from 50%–95% after 7 days and 57%–95% after 14 days. The
disseminated viral infection rates measured through the pres-
ence of virus in mosquito legs in tetracycline-treated A. aegypti
ranged from 10%–23% and 37%–43% after 7 and 14 days,
respectively. Disseminated infections in the Wolbachia-free
wild-type Cairns3 strain of A. aegypti ranged from 5%–13%
and 20%–33% after 7 and 14 days, respectively (Table 1) (p <
0.001, chi-square). In one experiment (Table 1, Exp 4) when
mosquitoes were fed the highest titer (107.8 Logs) of DENV-2
a small number of Wolbachia-infected mosquitoes tested posi-
tive for DENV-2 at both 7 and14 days post infection (5 and 8%,
respectively) but this was significantly fewer than Wolbachia
uninfected controls (63%–78% and 70%–75%, respectively)
(p < 0.001, chi-square).
To provide a more conservative test of Wolbachia-mediated
interference, mosquitoes were intrathoracically injected with
DENV-2. These experiments circumvented the midgut barrier
to infection (Woodring et al., 1996) and allowed for the delivery
of a repeatable inoculating dose (around 2,750 infectious parti-
cles/mosquito) of DENV-2 that produced consistent high-titer
infections in control mosquitoes. Accumulation of genomic
(+RNA) and anti-genomic (-RNA) RNA strands was assessed at
5 and 14 days post injection by quantitative real time PCR using
DENV-2 specific primers (Richardson et al., 2006). At both time
points, the amount of DENV-2 RNA present was reduced by
up to 4 logs in both the PGYP1 and PGYP1.out Wolbachia-
infected mosquito strains compared to their paired tetracycline
treated counterparts (Figure 1, and Table S1 available online).
Furthermore, when mosquito saliva collected from mosquitoesell 139, 1268–1278, December 24, 2009 ª2009 Elsevier Inc. 1269
Figure 1. Quantitative PCR Analysis of Dengue Virus in Mosquitoes
Two strains of Wolbachia-harbouring (+ Wolb) A. aegypti mosquitoes (PGYP1 and PGYP1.out) and their tetracycline treated counterparts (- Wolb) (PGYP1.tet and
PGYP1.out.tet) were intrathoracically injected with DENV-2 and the virus RNA was estimated by real-time PCR.
(A) Genomic RNA (+RNA) in thorax and head 5 days post-infection (dpi), abdomen 5 dpi and whole mosquito 14 dpi.
(B) Anti-genomic RNA (-RNA) in thorax and head 5 dpi, abdomen 5 dpi and whole mosquito 14 dpi. Bars represent grand means ± SEM calculated across four
independent replicate experiments. *p < 0.05 by Mann-Whitney U test. See also Table S1.14 days postinjection was tested for the presence of infectious
virus by CCEIA, none of the Wolbachia-infected mosquitoes
samples tested positive for virus (data not shown). A dramatic
reduction in viral protein synthesis was also observed by immu-
nofluorescent microscopy (IFA) (Figures 2A–2F) and western blot
analysis (Figure S1).
Double immunofluorescent staining of paraffin sections of Wol-
bachia-uninfected control mosquitoes 14 days post-injection
showed DENV-2 infection predominantly in mosquito fat body,
ommatidia (Figures 2A–2F) and nervous system. DENV-2 was
not detected in any of these tissues in Wolbachia-infected
mosquitoes (PGYP1 and PGYP1.out) whereas Wolbachia was
clearly visible in the fat tissue, ommatidia (Figure 2), brain, ovaries,
and malpighian tubules. Only in a few rare individuals was DENV-
2 detected in patches of fat tissue in PGYP1.out mosquitoes.
However in these cases Wolbachia and DENV-2 were not
co-localized in the same cells and DENV-2 was only seen in occa-
sional patches of cells that were not infected with Wolbachia
(Figure 2G). The presence of DENV-2 in some injected PGYP1.-
out mosquitoes was also confirmed by western blot (Figure S1A).
Wolbachia and Chikungunya Virus
We then went on to determine if the virus interference phenotype
would extend to the alphavirus CHIKV. The virus strain used in
the experiments contained the Ala to Val mutation in the
membrane fusion glycoprotein E1 gene (E1-A226V), which has
been linked to increased infectivity in A. albopictus (Tsetsarkin
et al., 2007). An Australian population of A. aegypti was recently
shown to also be a highly efficient laboratory vector of this virus
strain (van den Hurk et al., 2009).1270 Cell 139, 1268–1278, December 24, 2009 ª2009 Elsevier Inc.Mosquitoes were exposed to a blood/virus mixture containing
106.4 CCID50/ml of CHIKV, and at various time points postexpo-
sure, mosquitoes were processed to quantify the number of viral
RNA copies using qPCR and CHIKV-specific primers and probes
(van den Hurk et al., 2009). Immediately after feeding, the number
of CHIKV genomic (+ RNA) RNA copies in the body and head were
comparable for all three lines, suggesting that they imbibed
similar amounts of virus (Table 2). The median number of copies
decreased in all three lines on day 2, prior to it increasing in the
PGYP1.out.tet and Cairns3 mosquitoes to its highest level at
day 14-postexposure. Day 14 infection rates were 87% and
79% for the PGYP1.out.tet and Cairns3 controls and 17% for
the Wolbachia infected PGYP1.out line (p < 0.001, chi-square).
In all three mosquito groups, CHIKV RNA was detected in the
legs and wings immediately after feeding (Table 2). This may
represent either direct contact between the legs and/or wings
and the blood/virus mixture or a rupture of the mesenteron,
which released virus directly in the hemolymph (Turell, 1988).
After day 0, CHIKV was not detected in the legs and wings of
any PGYP1.out (+ Wolb) mosquitoes. In contrast, on all days
postexposure, virus was detected in the legs and wings of
PGYP.out.tet and Cairns3 control mosquitoes (- Wolb) and by
day 14, the virus was detected in the legs and wings of 100%
and 90%, respectively, of mosquitoes that had positive bodies
and heads (p = 0.125, chi-square).
Wolbachia and Plasmodium
Considering that the viral interference effect appeared robust
for two unrelated arboviruses we then tested the effect on the
protozoan parasite P. gallinaceum. While not a human pathogen,
Figure 2. Localization of Wolbachia and Dengue
Virus in A. aegypti Mosquitoes
Double immunofluorescence staining of mosquito
sections showing the localization of dengue virus (red)
and Wolbachia (green). Sections were probed simulta-
neously with polyclonal anti-wsp antibody (Wolbachia)
and monoclonal anti-DENV antibody 4G4, followed by
Alexa 488 (green) and Alexa 594 (red) conjugated
antibodies, respectively. DNA (blue) is stained with DAPI.
In panels (A, B, E, F, and G), the red, green and blue
channels are merged. C and D show only red and green
channels merged. (A, C, E) PGYP1.tet (- Wolb) mosqui-
toes, 14 days post-DENV-2 thoracic injection. Dengue
virus is visible in ommatidia cells (A and C) and fat tissue
(E). (B, D, F) PGYP1 mosquitoes (+ Wolb), 14 days post-
DENV-2 thoracic injection. Wolbachia can be seen in
ommatidia cells and brain (B and D) and fat tissue (F). In
contrast no dengue virus was detected. (G) Cellular exclu-
sion of DENV-2 by Wolbachia. The presence of both
Wolbachia and DENV-2 was observed at very low
frequency in a small number of Wolbachia-infected out-
crossed mosquitoes, 14 days post-DENV-2 injection.
Dengue is only apparent in cells lacking Wolbachia
however. Scale bars: A-D, G: 50 mm; E, F: 20 mm. See
also Figure S1.this species of malaria parasite is known to be able to infect A.
aegypti mosquitoes in the laboratory. Since no species of anoph-
eline mosquitoes are known to carry natural Wolbachia infec-
tions and stable Wolbachia transinfected lines have yet to be
generated, we considered the A. aegypti – P. gallinaceum model
system most appropriate for testing effects on malaria parasites.
Wolbachia-infected and uninfected A. aegypti mosquitoes
(PGYP1.out and PGYP1.out.tet strains) as well as a susceptible
strain of Aedes fluviatilis were fed in parallel on P. gallinaceum in-
fected chickens. A. fluviatilis has a broad geographical distribu-
tion in Latin America and has been used in the laboratory asCell 139, 1268–12a safe avian malaria (P. gallinaceum) model
vector, as it does not naturally transmit DENV
or yellow fever virus (Tason de Camargo and
Krettli, 1981).
Seven days post-feeding on infected
chickens, mosquito midguts were dissected
and presence and number of Plasmodium
oocysts assessed. The wMelPop-CLA infection
significantly reduced (p < 0.0001, chi-square)
the frequency of mosquitoes in the population
infected with at least a single oocyst and so
potentially able to transmit Plasmodium (Fig-
ure 3A) from 74% (tet controls) down to 42%.
The presence of Wolbachia also reduced the
number of oocysts present in mosquitoes that
were infected with the parasite (Figures 3A and
3B). To quantify the difference in parasite loads,
15 days after infection mosquitoes were
collected and the DNA was extracted. The rela-
tive abundance of Plasmodium genomic DNA
was measured by qPCR of the 18S ssu rRNA
gene (Schneider and Shahabuddin, 2000) andnormalized to the mosquito Actin gene. The results showed the
same pattern of interference as observed from oocyst count
data. In PGYP1.out mosquitoes Plasmodium genomic DNA
was 26-fold less abundant than in PGYP1.out.tet lines
(Figure 3C). Immunofluorescence analysis using an anti-CSP
(Plasmodium circumsporozoite protein) monoclonal antibody
showed the presence of mature oocysts in both mosquito
species (Figure S2B), but very rarely in Wolbachia-infected
mosquitoes.
When we incubated the mosquito sections with an anti-
Wolbachia (wsp) antibody we serendipitously discovered78, December 24, 2009 ª2009 Elsevier Inc. 1271
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1272 Cell 139, 1268–1278, December 24, 2009 ª2009 Elsevier Inc.a Wolbachia infection in A. fluviatilis mosquitoes indicating that
this species of mosquito was naturally infected with Wolbachia.
PCR using Wolbachia general wsp primers (Braig et al., 1998;
Zhou et al., 1998) amplified a fragment from all A. fluviatilis
tested. Sequence of the amplified DNA indicated that this Wol-
bachia strain (named wFlu) belongs to the Wolbachia B super-
group and is distantly related to wMelPop-CLA. qPCR analysis
revealed that the density of wFlu in A. fluviatilis is about 20-fold
lower than the density of wMelPop-CLA in A. aegypti (Figure S3).
We then examined the tissue localization of Wolbachia in both
mosquito species and whereas wMelPop-CLA is distributed
throughout most tissues of the mosquito including the fat
body, anterior midgut, muscle, nervous tissue, malpighian
tubules and ovaries, wFlu is present only in ovaries, malpighian
tubules and less frequently in the head, but absent from omma-
tidia (Figures 4 and S3).Immunity Genes
To examine whether resistance of Wolbachia infected mosqui-
toes to pathogen infection may be related to stimulation or
priming of the mosquito innate immune system, we quantified
the expression of a sample of immune genes. It was recently
demonstrated that some immune genes are differentially regu-
lated in A. aegypti mosquitoes infected with dengue virus (Xi
et al., 2008). Interestingly, regulation of the immune pathway
genes in these mosquitoes was also stimulated by their natural
gut microbiota and rearing mosquitoes aseptically, and so
depleting their bacterial flora, resulted in a 2-fold increase of
dengue virus in the midgut (Xi et al., 2008). We chose a subset
of the genes that were shown to be upregulated upon dengue
virus infection to assess the effect of Wolbachia infection on
the mosquito immune system.
The expression levels of eleven immune pathway genes in the
wMelPop-CLA infected PGYP1.out and its uninfected control
line were compared for two independently reared cohorts of
mosquitoes (Figure 5). In each of the experiments four genes en-
coding representatives of the immune effector molecules cecro-
pin, defensin, thio-ester containing proteins (TEP) and C-type
lectins were significantly upregulated in the presence of
wMelPop-CLA, whereas FREP18 (fibrinogen-related protein
18) levels remained unchanged (Figures 5A and 5B). In contrast,
while a statistically significant (p < 0.05) differential mRNA
expression between mosquitoes with and without Wolbachia
was observed for a subset of the genes from the Toll, IMD
and Jak/STAT signaling pathways (Figure 5C Experiment 1-
Rel 1A and SOCS36E; Figure 5D Experiment 2 – IMD and
Rel 2) these differences were inconsistent across the two exper-
iments, suggesting that the variation between cohorts was
greater than any differences induced by Wolbachia. In addition,
in these cases the fold-change of mRNA expression was low
(below 2-fold), whereas the effector genes were induced as
much as 100-fold by the presence of Wolbachia (Figure 5A
and 5B). These results indicate that the presence of wMelPop-
CLA in mosquitoes stimulates expression of at least some
immune effector genes, although a clear stimulation of the clas-
sical innate immune signaling pathways was not repeatably
identified.
Figure 3. Plasmodium gallinaceum Detection in
Aedes spp. Mosquitoes
A. aegypti and A. fluviatilis mosquitoes were fed on
P. gallinaceum infected chickens and parasite was
detected.
(A) Box plots of median numbers and 25 (bar below
median) and 75 (above median) percentiles of oocyst
intensities, 7 days postinfection in wMelPop-CLA infected
(PGYP1.out, +Wolb) or uninfected (PGYP1.out.tet, -Wolb)
A. aegypti and in A. fluviatilis mosquitoes (***p < 0.0001 by
Mann-Whitney U test). Percentage of mosquitoes contain-
ing at least one oocyst is shown above the graph.
(B) Mercurochrome staining of mosquito midguts showing
P. gallinaceum oocysts (arrows) in wMelPop (+Wolb) in-
fected and uninfected (-Wolb) and in A. fluviatilis mosqui-
toes, seven days post-infection (1003 magnification).
(C) Quantitative PCR analysis 15 days after infection
showing the relative abundance of Plasmodium 18S ssu
rRNA sequences in comparison to Actin gene (**p <
0.005, ***p < 0.0001 by Mann-Whitney U test). See also
Figure S2.DISCUSSION
The finding that the wMelPop-CLA Wolbachia infection reduces
the ability of two distantly related arboviruses and a malaria
parasite from establishing productive infections in the mosquito
shows that the pathogen interference effect of the wMelPop-
CLA strain is general and fundamental. The mechanism is
currently unclear although our data suggest that immune effector
genes are upregulated in the mosquito in the presence of the
wMelPop-CLA strain and are likely to play a role, even though
key components of the currently accepted signaling pathways
for these effectors do not seem to be transcriptionally modulated
by Wolbachia.
It is also possible that the observed interference effect might
relate to competition for key host cell components. This is sup-
ported by the observation that DENV-2 infection was only
observed in Wolbachia infected mosquitoes in cells that lacked
the Wolbachia infection (Figure 2G). It is known, for example,
that insects need to obtain cholesterol and other fatty acids
from their diet (Blitzer et al., 2005) and that Wolbachia and related
bacteria also lack the biosynthetic capability to synthesize
cholesterol and need to obtain it from the host insect (Lin and Ri-
kihisa, 2003; Wu et al., 2004). In addition cholesterol is known to
be a key fatty acid required for successful Flavivirus and Alpha-
virus replication that must be obtained from the host cell (Lu
et al., 1999; Mackenzie et al., 2007). Similarly Plasmodium is
also known to depend on host lipids in the mosquito stage (Atella
et al., 2009). The relative importance of innate immune effectors
and alternative mechanisms such as competition for critical host
cell components such as cholesterol remains to be determined.
One critical paradox relating to Wolbachia infection and reduc-
tions in mosquito vector competence is the observation that
some mosquito species that naturally carry Wolbachia infectionsCsuch as A. albopictus are known to be competent vectors for
a range of pathogens including DENV and CHIKV. Our fortuitous
discovery that our control mosquito species A. fluviatillis
supports very high oocyst loads, despite the presence of a natu-
rally occurring Wolbachia strain, allowed us to provide an expla-
nation for this observation. It is known that different Wolbachia
strains commonly display quite variable somatic tissue distribu-
tion and densities (Dobson et al., 1999; Dutton and Sinkins, 2004;
Miller and Riegler, 2006). Our analysis of A. fluviatilis shows that
the wFlu Wolbachia strain has a very restricted tissue tropism in
its host mosquito (Figures 2, 5, and S3) and overall Wolbachia
densities are much lower (20-fold) than the wMelPop-CLA infec-
tion in A. aegypti (Figure S3A). This likely explains why no Plas-
modium interference effect is observed in this species and
may explain why A. albopictus is known to be a competent
vector for arboviruses while being naturally infected with Wolba-
chia. The wMelPop Wolbachia strain in Drosophila is known to be
unusual in that it grows to high densities (Min and Benzer, 1997)
and has broad tissue tropism in A. aegypti (Figures 2 and 5),
which may underpin its ability to so effectively interfere with
both virus replication and parasite development.
Our results have significant implications for any future control
measure based on the use of life-shortening Wolbachia.
Currently the wMelPop-CLA infection has been demonstrated
to reduce average mosquito lifespan by approximately 50% in
the laboratory (McMeniman et al., 2009) that while sufficient to
greatly reduce transmission could still allow some mosquitoes
to live longer than the extrinsic incubation period for most human
pathogens. The observed interference effect reported here
appears sufficiently strong that it would act in conjunction with
the life-shortening effect to control arbovirus transmission.
Life-shortening effects on mosquitoes would become secondary
and only act on individuals that might escape the direct viralell 139, 1268–1278, December 24, 2009 ª2009 Elsevier Inc. 1273
Figure 4. Wolbachia Distribution in Aedes spp. Mosquitoes
Fluorescence in situ hybridization showing the localization of Wolbachia (in red) in different tissues of A. aegypti and in A. fluviatilis mosquitoes. Sections
were hybridized with two Wolbachia specific 16S rRNA probes labeled with rhodamine. DNA is stained with DAPI (blue). A green filter is used to provide contrast.
The top diagram has been adapted from (Jobling, 1987).
(A) Anterior part of the digestive system, showing the salivary glands (SG) and the cardia (C), together with the thoracic ganglion (G) of uninfected A. aegypti
(-Wolb), PGYP1.out (+Wolb) and A. fluviatilis mosquitoes. Panels B). Fat tissue showing the presence of wMelPop-CLA in PGYP1.out (+ Wolb) mosquitoes
but absence of the bacteria in PGYP1.out.tet (-Wolb) and in A. fluviatilis. C) wMelPop-CLA is present in the fat tissue (FT) surrounding the gut in PGYP1.outinterference effect. The combined action of two distinct Wolba-
chia effects, lifespan reduction and virus interference, should
also reduce the risk of resistance formation to the strategy.1274 Cell 139, 1268–1278, December 24, 2009 ª2009 Elsevier Inc.The inhibitory effect of wMelPop-CLA Wolbachia against
P. gallinaceum is a promising step toward the possible applica-
tion of this strategy to control human malaria. Anopheles
Figure 5. Immune Gene Regulation in Response toWolbachia Infection
RT-qPCR analysis of mRNA expression from selected immune genes of PGYP1.out and PGYP1.out.tet mosquitoes. Graphs show the target gene to house-
keeping gene ratio for the genes indicated from the immune pathways. Box plots of median numbers and 25 (bar below median) and 75 (above median)
percentiles of 10 individual mosquitoes from a single cohort. Results from two independently reared cohorts are shown (cohort 1 [A and C]; cohort 2 [B and
D]). Statistically significant medians by Mann Whitney-U test (*p < 0.05, **p < 0.01 and ***p < 0.001) are indicated. Fold-change for the gene is shown above
the box plots.mosquitoes, as A. aegypti, are not naturally infected with Wolba-
chia, therefore transinfection experiments into these vector
species are crucial to determine whether Wolbachia can also
block human malaria in anopheline vectors. As the bacterium
is able to establish somatic infection in the human malaria vector
Anopheles gambiae (Jin et al., 2009), it is likely that the same
interference effect may also be present when a stable infection
of Wolbachia becomes available.
EXPERIMENTAL PROCEDURES
Mosquitoes
Five different A. aegypti lines were used including the original inbred wMel-
Pop-CLA infected line (PGYP1) and its tetracycline-cured counterpart
PGYP1.tet (McMeniman et al., 2009). A genetically diverse line derived
from PGYP1, named PGYP1.out was generated by backcrossing PGYP1
for three generations to F1 males of 52 independent field-collected isofe-
male lines from Cairns, Australia. Two further generations of backcrossing
were conducted with F2 field-collected material (wild-type from Cairns,
Australia). The backcrossing scheme used here is expected to replace
96.9% of the original inbred genotype. A tetracycline-cured counterpart
(PGYP1.out.tet, -Wolb) was generated by antibiotic treatment of back-
crossed adults, followed by two generations of recovery and re-colonization
with gut bacteria as previously described (McMeniman et al., 2009). A genet-
ically diverse wild-type line was also generated at the same time from
field-collected material sourced from 245 ovitraps across seven suburbs
of Cairns, Australia in late 2008 and named Cairns3. For the malaria exper-
iments, a susceptible A. fluviatilis strain (Rodrigues et al., 2008) was used in
parallel with PGYP1.out (+ Wolb) and PGYP1.out.tet (-Wolb) A. aegypti
mosquitoes.
Insects were kept in a controlled environment insectary at 25C, 80% RH,
12 hr light regime. Larvae were maintained with fish food pellets (Tetramin,
Tetra) and adults were offered 10% sucrose solution, ad libitum. Adult femalesCwere bloodfed on human volunteers (UQ human ethics approval 2007001379;
QIMR approval P361) for egg production. Three- to five-day-old female
mosquitoes were used for the DENV and malaria infection experiments. Seven
day old females were used for the CHIKV experiments.Viruses
Dengue virus
Dengue virus serotype 2 (DENV-2) (92T) was isolated from human serum
collected from a patient from Townsville, Australia, in 1992. Virus stocks
were passaged five times in Aedes albopictus cell line (C6/36) grown in
RPMI 1640 medium supplemented with 10% fetal calf serum (FCS), penicillin
(100 mg/ml), streptomycin (100 mg/ml), and 13 glutamax (Invitrogen), and
maintained at 28C.
Supernatants from infected cell lines (C6/36) were collected 5 days after
infection, separated into 0.5 ml aliquots, and frozen at 80C. Virus used in
microinjection experiments was obtained from thawed stocks of above and
had a titer of 107.6 CCID50 per ml. To prepare the DENV-2 for oral feeding,
the frozen virus stock was passaged once more through C6/36 cells and the
supernatant was harvested at 5 d and then mixed with blood to formulate
a bloodmeal for feeding. Virus solution with higher titer (108.85 CCID50/ml)
was obtained by harvesting the viral supernatant and the intracellular virus
from cell lysates.
Chikungunya Virus
CHIKV strain 06113879, isolated from a viremic traveler returning from
Mauritius to Victoria, Australia in 2006 was provided by the Victorian Infectious
Diseases Research Laboratory, Melbourne, Australia. Cultures were grown at
37C in Vero (African green monkey kidney) cells for 4 days before the super-
natant was harvested and frozen at 80C. This CHIKV stock was passaged
once more in Vero cells and the virus was concentrated from 1.8 L of infected
culture supernatant via ultracentrifugation at 10 000 g for 17 hr at 4C. Pelleted
virus was resuspended in 20 ml of Opti-MEM reduced serum medium
(GIBCO BRL, Invitrogen, California) supplemented with 10% FCS before
aliquots of the prepared virus were frozen at 80C. The stock concentration
had a final viral titer of 108.0 CCID50/ml.ell 139, 1268–1278, December 24, 2009 ª2009 Elsevier Inc. 1275
Exposure of Mosquitoes to Viruses
Intrathoracic Injection with DENV-2
Female mosquitoes were briefly anesthetized with CO2 and placed on a glass
plate over ice. Insects were handled with forceps under a dissecting scope
and injected into their thorax (pleural membrane) with a pulled glass capillary
and a handheld microinjector (Nanoject II, Drummond Sci.). 69 nl of DENV-2
stock was injected into each mosquito, which corresponds to approx. 2,750
virus particles/ mosquito. (See Supplemental Experimental Procedures for
details).
Oral Feeding with DENV-2 and CHIKV
Mosquitoes were starved for 24 hr and then transferred to 1L or 2.5L plastic
feeding containers. Prior to feeding, DENV-2 was harvested from C6/36 cell
culture supernatant and diluted 1:5 in defibrinated sheep’s blood. For the
CHIKV experiments, frozen aliquots of stock virus were rapidly thawed, and
diluted in washed defibrinated sheep blood and 1% sucrose. Blood-virus
mixtures were maintained at 37C for 1 hr and 4 hr for DENV-2 and CHIKV,
respectively, using membrane feeders (Rutledge et al., 1964) and covered
with a porcine intestine as the membrane. After feeding, mosquitoes were
anesthetized using CO2 and partially or non-engorged mosquitoes were dis-
carded (see Supplemental Experimental Procedures for details).Cell Culture Enzyme Immunoassays
Titration of DENV-2 and CHIKV stocks and blood/virus mixtures was per-
formed using a CCEIA method (Broom et al., 1998). For DENV-2, C6/36 cell
monolayers (60%–90% confluent) in 96-well plates were inoculated with 50
ml/well of virus dilutions and plates were incubated at 28C with 5% CO2 for
5 d. Cell monolayers were then fixed and examined for DENV-2 antigens using
a cocktail of flavivirus cross-reactive monoclonal antibodies (4G4 and 4G2)
(Clark et al., 2007; Gentry et al., 1982). For CHIKV, all titrations were performed
in Vero cells, which were incubated at 37C with 5% CO2. After 7 days, plates
were examined for cytopathic effect (CPE), which was confirmed using the
CCEIA and the broadly reactive alphavirus monoclonal antibody, B10 (Broom
et al., 1998).
Plasmodium gallinaceum
Two to three day-old White Leghorn chickens were infected through intra-peri-
toneal or intradermal injection of Plasmodium gallinaceum 8A strain parasit-
ized blood (Rodrigues et al., 2008). Parasitemia was determined every other
day through Giemsa-stained blood smears. Ten microscopic fields were
examined under immersion oil to count one hundred red blood cells and deter-
mine the ratio of infected cells. Presence of gametocytes and rising parasite-
mia was ensured in order to enhance the chance of mosquito infection. Before
infection mosquitoes were deprived of sugar solution overnight and on the
next morning chickens were placed on top of the cages and mosquitoes
were fed for about 45 min. Only bloodfed female mosquitoes were kept for
further observations. Four independent experiments were performed with
independent cohorts. Seven days after bloodfeeding mosquitoes had their
midguts dissected in 1 PBS and after staining the midguts with 0.2% Mercu-
rochrome solution oocysts were counted under a microscope (DIC, 100X).
Fifteen days after infection mosquitoes were collected and DNA was extracted
(QIAGEN Blood & Tissue kit) for Plasmodium detection, using around 1 ng of
genomic DNA in quantitative PCR reactions. Primers for the Plasmodium
spp. 18S ssu rRNA gene (Schneider and Shahabuddin, 2000) were used for
parasite amplification and A. aegypti Actin was used as a host control gene
(primer sequences in Supplemental data). Analyses were performed with
qGENE (Joehanes and Nelson, 2008) and Mann Whitney-U tests (STATISTICA
V8, StatSoft, Inc.) to compare relative abundance between lines.Quantitative DENV PCR Analysis
Individual frozen mosquito bodies or body parts were placed into 2 ml screw
cap vials with a glass bead (2 mm diameter, Sigma-Aldrich). 200 ml of Trizol
(Invitrogen) was added and the sample homogenized for 150 s using a Mini
BeadBeater (Biospec Products). 40 ml of chloroform was added to each tube
and samples were thoroughly vortexed for 10 s. Tubes were centrifuged
for 15 min at 14,000 g and 4C and the supernatant containing the RNA was
transferred to new tubes. RNA was precipitated with 40 ml of isopropanol,
washed with 200 ml of 70% ethanol and resuspended in 25 ml of RNase-free1276 Cell 139, 1268–1278, December 24, 2009 ª2009 Elsevier Inc.milli-Q water. Samples were maintained at 80C until further analysis (See
Supplemental Experimental Procedures for details).
CHIKV RT-qPCR Analysis
Individual frozen mosquito bodies and heads or legs and wings were homog-
enized for 3 min in 1 ml of Opti-MEM reduced serum medium using glass
beads and a mechanical homogenizer (Spex Industries, Edison, NJ). The
supernatant from each sample was removed for potential virus isolation and
stored at 80C. The remaining mosquito pellet from each sample was resus-
pended in 200 ml of Opti-MEM reduced serum medium and TRIzol LS
reagent (Invitrogen) and homogenized again as described above. After incuba-
tion at room temperature for 5 min and addition of 40 ml of chloroform, the
entire homogenate for each sample was then vortexed for 15 s and transferred
to a pre-spun Phase Lock Gel Heavy tube (5 Prime, GmbH, Germany). The
lysed contents of each tube were allowed to settle for 5 min and organic and
aqueous phases were separated by centrifugation at 16,000 g for 10 min.
Aqueous phases were recovered from each tube before total RNA was
extracted using a modification of the RNeasy Mini Kit protocol (QIAGEN,
Australia) and on column-DNase treatment. RNA was eluted with 30 ml of
RNase-free H2O and a final centrifugation step for 1 min. RNA samples were
stored at80C prior to analysis by RT-qPCR. RNA standards were produced
for the relative quantification of CHIKV RNA copy numbers normalized to RNA
levels of the A. aegypti house-keeping gene RpS17 (See Supplemental Exper-
imental Procedures for details).
Immune Genes
PGYP1.out and PGYP1.out.tet mosquitoes were analyzed by RT-qPCR for a
selection of immune genes. Two biologically independent cohorts of 10
sugar-fed, 5-6 day old, female mosquitoes were collected and analyzed
from each mosquito line. Total RNA was extracted from whole mosquitoes
using TRI REAGENT (Molecular Research Center, Inc.) or RiboZol (AM-
RESCO). The RNA samples were DNase treated (Promega) and reverse
transcribed using random primers and SuperScript III Reverse Transcriptase
(Invitrogen). Quantitative PCR was carried out as per Platinum SYBR Green
protocol (Invitrogen). Primer sequences for REL1, REL2, CECG and DEFC
were obtained elsewhere (Xi et al., 2008) and the other primers were designed
using gene sequences obtained from VectorBase (see Supplemental data).
The temperature profile of the qPCR was 95C for 2 min, 50C for 2 min and
40 cycles of 95C for 10 s, 60C for 10 s and 72C for 20 s. The house-keeping
gene RpS17 (Cook et al., 2006) was used to normalize expression. Target gene
to house-keeping gene ratios were obtained for each biological replicate
using QGene 4.2 (Joehanes and Nelson, 2008). Treatment effects on the
expression ratios were examined using Mann Whitney-U tests in STATISTICA
V8 (StatSoft, Inc.) and fold change was calculated by the REST method (Pfaffl
et al., 2002).
Immunofluorescence
Following the removal of legs and wings, 14 dpi mosquitoes were fixed over-
night at 4C in 4% (w/v) paraformaldehyde in PBS, containing 0.5% (v/v) Triton
X-100. Fixed mosquitoes were dehydrated in an ethanol series of 50%–100%
ethanol, followed by two toluene treatments and then infiltrated with paraffin
wax (Paraplast-Xtra, McCormick Scientific) at 60C. Paraffin-embedded
mosquitoes were sectioned using a rotary microtome to obtain 8 mm sections
that were adhered to superfrost plus slides (Menzel-Gla¨ser). Slides were dried,
de-paraffinated in 100% xylene, rehydrated in an ethanol series and washed in
PBS-T before being blocked overnight in 2% (w/v) bovine serum albumin
(BSA) in PBS-T at 4C. Sections were then incubated simultaneously for 1 hr
with anti-rabbit wsp (1:100) and anti-dengue (1:10) 4G4 or anti-Plasmodium
CSP (Krettli et al., 1988) antibodies (1:100) (both monoclonal, developed in
mouse), in blocking solution. Tissue sections were washed twice with PBS-T
and then incubated simultaneously with Alexa-conjugated secondary anti-
bodies (Alexa-488 developed in rabbit or Alexa-594, developed in mice,
respectively, Molecular Probes, Invitrogen) diluted 1:1000 each in blocking
solution for 1 hr at room temperature. After two washes in PBS-T, the slides
were incubated in DAPI for 10 min, rinsed in PBS-T and then mounted using
an antifading reagent (ProLong, Invitrogen). Immunostaining was analyzed
with a Zeiss Axio Imager II epifluorescence microscope equipped with an
Axiocam camera, using the same exposure conditions for each filter channel.
Photos are representative of at least 10 mosquitoes of each treatment.
Fluorescence In Situ Hybridization
Paraffin-embedded mosquitoes were sectioned and de-paraffinated as
described above. Sections were then dehydrated in an ethanol series
and hybridized overnight at 37C in a hybridization buffer containing 4X
SSC, 50% formamide, 250 mg/ml dextran sulfate, 250 mg/ml poly(A),
250 mg/ml tRNA, 250 mg/ml salmon sperm DNA, 100 mM DTT and 0.53
Denhardt’s solution and 200 ng of Wolbachia specific 16S rRNAprobes
(W2: 50- CTTCTGTGAGTACCGTCATTATC-30 and W3: 50-AACCGACCCT
ATCCCTTCGAATA-30) labeled at the 30 end with rhodamine. Both probes
are 100% homologous to both wMelPop and wFlu. Following overnight hybrid-
izations, sections were washed twice in 1X SSC containing 10 mM DTT and
twice in 0.5X SSC containing 10 mM DTT for 15 min each at 55C, followed
by a 10 min wash at 0.53 SSC containing 10 mM DTT and 1 mg/ml DAPI. Slides
were briefly rinsed in water, mounted using an antifading reagent (ProLong,
Invitrogen) and observed and photographed as described above.SUPPLEMENTAL DATA
Supplemental Data include three figures, one table, Supplemental Experi-
mental Procedures, and Supplemental References and can be found with
this article online at http://www.cell.com/supplemental/S0092-8674(09)
01500-1.
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